SavedAdd your journal

Journals / Journal of Neurological Sciences (Turkish) / 2013 / Cilt: 30 - Sayı: 3

Fentanil ile Kronik Ağrı Tedavisi Gören Bir Hastada Gelişen Bağımlılığa Multidisipliner Yaklaşım

A Multidisciplinary Approach to Addiction Developed in a Patient Receiving Chronic Pain Treatment with Fentanyl

Can EYİGÖR
Meltem UYAR
İsmail ÖZEL
A. Ender ALTINTOPRAK
Pages
573–578
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim was to attractattention to the importance of standardizing and controlling treatments with this group ofmedication in our country where family medicine is becoming widespread.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fentanyl, an opioid analgesic, started to be used more widely in patients with chronic painwho do not respond to a standard pain treatment.
📊
Key Findings & Data:Reports of cases involving abuse andaddiction are increasing rapidly when it is used for a reason other than medical treatment.This article presents a case where fentanyl was started for chronic pain treatment butaddiction developed after a short time and discusses how the use of opioid analgesics can beregulated in patients with chronic pain in the light of the literature.
💡
Conclusion & Impact:The aim was to attractattention to the importance of standardizing and controlling treatments with this group ofmedication in our country where family medicine is becoming widespread.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Fentanyl, an opioid analgesic, started to be used more widely in patients with chronic painwho do not respond to a standard pain treatment. Reports of cases involving abuse andaddiction are increasing rapidly when it is used for a reason other than medical treatment.This article presents a case where fentanyl was started for chronic pain treatment butaddiction developed after a short time and discusses how the use of opioid analgesics can beregulated in patients with chronic pain in the light of the literature. The aim was to attractattention to the importance of standardizing and controlling treatments with this group ofmedication in our country where family medicine is becoming widespread.

Özet

Fentanil, standart ağrı tedavisine yanıt alınamayan kronik ağrı hastalarında daha yaygınkullanılmaya başlanan bir opioid analjeziktir. Tıbbi tedavi gerekçesi dışında kullanıldığındakötüye kullanım ve bağımlılık geliştirdiğine ilişkin olgu bildirimleri hızla artmaktadır. Bumakale de kronik ağrı tedavisi için fentanil başlanan ancak kısa bir süre sonra bağımlılıkgelişen bir olgu sunulmakta ve literatür ışığında kronik ağrı hastalarında opioid analjezikkullanımının nasıl düzenlenebileceği tartışılmaktadır. Aile hekimliğinin yaygınlaştığıülkemizde bu grup ilaç tedavilerinin standardize edilmesi ve kontrol altında tutulmasınınönemine dikkat çekmek istenmiştir.

🔖

Cite This Article

EYİGÖR, C., UYAR, M., ÖZEL, İ., ALTINTOPRAK, A. E. (2022). Fentanil ile Kronik Ağrı Tedavisi Gören Bir Hastada Gelişen Bağımlılığa Multidisipliner Yaklaşım. Journal of Neurological Sciences (Turkish), Cilt: 30 - Sayı: 3, 573–578. https://ajindex.com/articles/565206

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Allan L, Richarz U, Simpson K, Slapp endel R. Transdermal Fentanyl Versus Sustained Release Oral Morp hine in Strong Op iod Naive Patients With Chronic Low Back Pain. Sp ine 2005; 30: 2484-90
  2. American Pain Society. Pain Control in the Primary Care Setting. Glenview, IL: American Pain Society, 2006
  3. Andersson GBJ. “Ep idemiological f eatures of chronic low-back p ain ” The Lancet, vol. 354, no. 9178, pp. 581–585, 1999
  4. Amass L, Bickel WK, Higgins ST, Badger G. Alternate-day dosing during bup renorp hine treatment of op ioid dep endence. Lif e Sci 1994; 17: 1215-1228
  5. Arkinstall W, Sandler A, Goughnour B, Babul N, Harsanyi Z,Darke AC. Eff icacy of controlled-release codeine in chronic non-malignant p ain: a randomized, p lacebo-controlled clinical trial. Pain 1995; 62: 169–78
  6. Arnold RM, Han PK, Seltzer D. Op ioid Contracts in Chronic Nonmalignant Pain Management: Obj ectives and Uncertainties. Am J Medicine 2006; 119: 292-6
  7. Bair M, Robinson R, Katon W, Kroenke K. “Dep ression and p ain comorbidity: a literature review, ” Archive sof Internal Medicine, vol. 163, no.20, pp. 2433–2445, 2003
  8. Bullingham RES, McQuay HJ, Moore A, Bennett MRD. Bup renorp hine kinetics. Clin Pharmacol Ther 1980; 28: 667-672
  9. Caldwell JR, Rap ap ort RJ, Davis JC, Off enberg HL, Marker H W,Roth SH, et al. Eff icacy and saf ety of a once-daily morp hin f ormulation in chronic, moderate-to-severe osteoarthritis p ain: results f rom a randomized, p lacebo-controlled, double-blind trial and an op en-label extension trial. J Pain Symp tom Manage. 2002; 23: 278–91
  10. Cherkin DC, Wheeler KJ, Barlow W, Deyo RA. Medica-tion use f or low back p ain in p rimary care. Sp ine (Phila Pa 1976) 1998; 23: 607-14
  11. Chou R, Fanciullo GJ, Fine P. et al. “Clinical guidelines f or the use of chronic op ioid therapy in chronic noncancer p ain, ” Journal of Pain, vol. 10, no. 2, pp. 113–130, 2009
  12. Eisenberg E, McNicol ED, Carr DB. Eff icacy and saf ety of op ioid agonists in the treatment of neurop athic p ain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA; 293: 3043-52
  13. Eriksen J, Jensen MK, Sj ogren P, et al. Ep idemiology of Chronic Non-Malignant Pain in Denmark. Pain 2003;106: 221-8
  14. Fishman SM, Manaj an G, Jung SW, Wilsey BL. The Trilateral Op iod Contract. Bridging the Pain Clinic and the Primary Care Physician Through the Op ioid Contract. J Pain Symp tom Manage. 2002; 24: 335- 44
  15. Fudala PJ, Jaf